AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GERON CORP Director's Dealing 2024

Jun 7, 2024

32370_dirs_2024-06-07_e63b45f7-6b9a-4ca7-9969-05f96f072715.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2024-06-06

Reporting Person: SCARLETT JOHN A (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-06	Employee Stock Option (right to buy)	$1.72	A	1000000	Acquired	2028-11-06	Common Stock (1000000)	Direct

Footnotes

F1: Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.